Photonic integrated circuits (PICs) have demonstrated exceptional potential for blood analysis, offering high sensitivity, multiplexed biomarker detection, precise quantification, and accurate analysis from tiny sample volumes. However, their manufacturing complexity and cost have limited broader adoption.

Luma has pioneered the world’s first polymer-based PICs, combining high optical performance with dramatically lower manufacturing costs. This breakthrough enables affordable at-home blood testing and the frequent, objective data needed for personalized disease management.